Clinical Trial Update: A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating KIVU-107 in participants with locally advanced or metastatic solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• KIVU-107

Snippet

Sponsor: Kivu Bioscience Inc. | Conditions: Advance Solid Tumors | Phase 1 | Status: RECRUITING